Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: SirRealist who wrote (94047)	4/7/2000 12:15:00 AM
From: Rock_nj	Respond to of 108040

The whole Clinton biotech thing has really been a misunderstanding from the beginning. What Clinton originally said (and had said previosuly) is that the basic genetic code should be public domain (not patentable). He never said that treatments developed using the basic genetic code were not going to be patenable. What he said on Wednesday was just a reaffirmation of previously public statements. I can't believe that the market didn't realize this simple fact. It just goes to show how willy nilly the market is these days. BTW, making the basic genetic code part of the public domain might speed research and help some of the biotech companies easily obtain the information they need to develope cures.